Abiopharma

(90% Positive) C4 Therapeutics Inc (CCCC) Announces Enrollment Update for Initiate Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Laboratory Corporation of America Holdings (LH) Files Form 8-K

BD Names Shawn Bevec as Senior Vice President of Investor Relations

Labcorp Declares Quarterly Dividend

(10% Negative) Nuvalent Inc (NUVL) Announces Delay in adult patients Trials for clinically proven kinase targets in cancer Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review

Zomedica Announces "Fourth Friday at Four" Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth

New Form EFFECT - cbdMD, Inc. Filed: 2026-01-13 AccNo: 9999999995-26-000160 Size: 1 KB

New Form EFFECT - BriaCell Therapeutics Corp. Filed: 2026-01-13 AccNo: 9999999995-26-000157 Size: 1 KB

New Form EFFECT - PLUS THERAPEUTICS, INC. Filed: 2026-01-13 AccNo: 9999999995-26-000164 Size: 1 KB

Director Patel Snehal 🟢 acquired 2.9K shares of Greenwich LifeSciences, Inc. (GLSI) at $27.54 Transaction Date: Jan 12, 2026 | Filing ID: 002112

Co-Diagnostics Inc (CODX) was removed from the list of traded instruments on NASDAQ exchange

Lexaria Bioscience Corp. (LEXXW) was removed from the list of traded instruments on NASDAQ exchange

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm

Perrigo Company plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRGO

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Lexaria Bioscience Corp. - Warrant.